Vera Therapeutics, Inc.
VERA
$22.57
-$0.04-0.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.53M | -51.69M | -43.43M | -46.63M | -33.71M |
| Total Depreciation and Amortization | 119.00K | 85.00K | 55.00K | 24.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.23M | 6.64M | 4.92M | 3.86M | 2.77M |
| Change in Net Operating Assets | 13.38M | -9.44M | -728.00K | 5.86M | 6.14M |
| Cash from Operations | -54.80M | -54.41M | -39.18M | -36.89M | -24.78M |
| Capital Expenditure | -208.00K | -187.00K | -645.00K | -238.00K | -89.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.75M | 15.50M | -220.74M | 38.56M | -22.59M |
| Cash from Investing | 28.54M | 15.32M | -221.38M | 38.32M | -22.68M |
| Total Debt Issued | 23.34M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 464.00K | 1.53M | 347.31M | 752.00K | 3.44M |
| Repurchase of Common Stock | -- | -- | 0.00 | -13.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.52M | -- | -21.36M | 0.00 | 0.00 |
| Cash from Financing | 20.29M | 1.53M | 325.96M | 739.00K | 3.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.97M | -37.56M | 65.39M | 2.17M | -44.02M |